We found that both LINC02325 and FNDC1-AS1 were upregulated in breast cancer and stomach cancer (Figures S4C, D), LINC02325 was upregulated in cervical cancer, colorectal cancer and esophageal cancer (Figure S4C) and FNDC1-AS1 was upregulated in bladder cancer and lung cancer (Figure S4D). Here, FNDC1 is linked to lung cancer.